TriKE (tri-specific killer cell engager) is a class of trispecific fbab, targeting NK cell antigen CD16, cancer/viral antigen, and includes tandemly linked scFv or VHH with an inserted IL-15 (interleukin-15) domain to stimulate NK cells [74,75,76]. Here, FCGR3A is linked to cancer.